Identification of angiogenesis-related hub genes in proliferative diabetic retinopathy via integrated transcriptomics and machine learning
Source check: Source checked. Not independent scientific confirmation.
Finding: Transcriptomic analyses with LASSO selected six candidate angiogenesis-associated genes in proliferative diabetic retinopathy. Functional experiments found that silencing LAMB1 reduced angiogenic activity in high-glucose-treated human retinal endothelial cells. These cell experiments support a candidate mechanism but do not establish therapeutic effects in patients.
Technology: LASSO regression is one of the learned-model steps used to select the six angiogenesis-associated genes from the transcriptomic candidates.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- LASSO regression is one of the learned-model steps used to select the six angiogenesis-associated genes from the transcriptomic candidates.
- Test and result
- Six genes were selected and evaluated in training/validation expression datasets; LAMB1 silencing was tested in high-glucose-treated human retinal endothelial cells.
- Limitation / still unknown
- In-vitro functional results do not establish in-vivo disease causality or treatment efficacy.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12763914/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary full text, including Methods and Results; publication date and first result-bearing version checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.